Experiencenew
Branding & Naming Experience
Brand Institute excels as the global leader in brand name and identity development, spanning healthcare, consumer products, and pharmaceutical standards. With over 75% of drug name approvals globally and unparalleled success in consumer and business-to-business branding, it sets the industry benchmark. Additionally, it dominates USAN/INN naming, with significant majorities in drug name approvals worldwide.
1,456
Healthcare Clients
4,777
Total Healthcare Names
1,621
USAN/INN (Nonproprietary)
456
Consumer/B2B Clients
980
Total Consumer/B2B Names
94
Corporate Identities
General Search
Showing 1 - 20 out of 20
Brand | Company | Service | Category |
---|---|---|---|
Brukinsa | BeiGene | ||
Tezspire | Amgen / AstraZeneca | ||
Paxlovid | Pfizer | ||
Hemlibra | Genentech | ||
Leqembi | Eisai / Biogen | ||
Caplyta | Intra-Cellular Therapies | ||
Bimzelx | UCB | ||
Entyvio | Takeda | ||
Rejoyn | Otsuka | ||
Adcetris | Pfizer Seagen | ||
Xtandi | Astellas / Pfizer | ||
Gemtesa | Sumitomo Pharma | ||
Lunesta | Waylis Therapeutics | ||
Livtencity | Takeda | ||
Avastin | Genentech | ||
Jeuveau | Evolus | ||
Lucentis | Genentech | ||
Gardasil | Merck | ||
Tremfya | Johnson & Johnson Johnson & Johnson Innovative Medicine | ||
Rybelsus | Novo Nordisk |